Загрузка...
Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures
OBJECTIVE: Intravenous (IV) levetiracetam (LEV) is approved for use in patients older than 16 years and may be useful in critically ill children, although there is little data available regarding pharmacokinetics. We aim to investigate the safety, an appropriate dosing, and efficacy of IV LEV in cri...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2946960/ https://ncbi.nlm.nih.gov/pubmed/19325512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PCC.0b013e3181a0e1cf |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|